종양약료 전문약사 제도에 대한 국내외 현황 조사와 비교 = Certified Oncology Pharmacist in Korea and Abroad: Comparing Systems and Understanding Inconsistencies

다국어 초록 (Multilingual Abstract)

Background : Due to the increasing number of patients with cancer and the complexity of anti-cancer drug therapies, it has become important for the pharmacists to develop specialized knowledge and skills to provide enhanced pharmaceutical care for these patients. The concept of certified oncology pharmacist, however, is relatively new in Korea. The objective of this study was to review the certified oncology pharmacist systems in Korea and two advanced countries (the US and Japan) and provide a comparative analysis.
Methods : The information related to certified oncology pharmacist system was obtained through the official websites of related organizations in each country. For obtaining the outcomes of pharmaceutical care services provided by certified oncology pharmacists, we explored the related domestic journals and PubMed database.
Results : The Korean Society of Health-system Pharmacists (KSHP) conducted the first certified oncology pharmacist examination in 2010 in Korea. To take this examination, completion of a related education course (at least a total of 360 hours) administered by the KSHP is essential. In the United States, the Board Certified Oncology Pharmacist (BCOP) was approved by the board of pharmacy specialty in 1996. In Japan, there are four types of the specialized pharmacist in oncology depending on the organization; Board Certified Pharmacist in Oncology Pharmacy, Japanese Society of Pharmaceutical Health Care and Sciences (JSPHCS)-certified Senior Oncology Pharmacist, JSPHCS-certified Oncology Pharmacist, and Accredited Pharmacist of Ambulatory Cancer Chemotherapy. In the US and Japan, a specialist is required to possess rigorous practical experience as well as academic training.
Conclusions : This study provides a deeper understanding of some of the practical issues that need to be addressed for improving the systems of certified oncology pharmacists in Korea.

참고문헌 (Reference)

1 병원약학교육연구원, "종양약료 전문약사 소개" 병원약학교육연구원

2 한국병원약사회, "전문약사제도 운영규정 제3조"

3 병원약학교육연구원, "전문약사 자격시험" 병원약학교육연구원

4 병원약학교육연구원, "전문약사 자격시험" 병원약학교육연구원

5 병원약학교육연구원, "전문약사 교육과정의 과목별 이수시간 및 인정 범위" 병원약학교육연구원

6 보건복지부, "의료법 제77조(전문의), 제78조(전문간호사)" 국가법령정보센터

7 이민정, "다직종 암환자 교육·상담에 대한 설문 개발과 환자 만족도 조사" 한국임상약학회 28 (28): 138-145, 2018

8 Merten JA, "Utilization of collaborative practice agreements between physicians and pharmacists as a mechanism to increase capacity to care for hematopoietic stem cell transplant recipients" 19 (19): 509-518, 2013

9 Suzuki S, "The impact of pharmacist certification on the quality of chemotherapy in Japan" 38 (38): 1326-1335, 2016

10 American College of Clinical Pharmacy, "Specialty Recertification"

11 American Society of Health-System Pharm, "Provider Status in California Paves Way for New Patient-Care Opportunities" American Society of Health-System Pharmacists

12 Iihara H, "Pharmacists contribute to the improved efficiency of medical practices in the outpatient cancer chemotherapy clinic" 18 (18): 753-760, 2012

13 Barry RG, "Our time has arrived!! Board of Pharmaceutical Specialties approves petition to recognize oncology pharmacy practice as a pharmacy specialty" 2 (2): 134-135, 1996

14 Board of Pharmacy Specialties, "Oncology Pharmacy; Eligibility Requirements" Board of Pharmacy Specialties

15 "Oncology Pharmacy Specialty Home Study Products co-sponsored by ACCP and ASHP"

16 North Carolina Board of Pharmacy, "North Carolina Pharmacy Rules" North Carolina Board of Pharmacy

17 Center NC, "National Cancer Center Hospital"

18 Arakawa-Todo M, "Management of adverse events in patients with metastatic renal cell carcinoma treated with sunitinib and clinical outcomes" 33 (33): 5043-5050, 2013

19 JASPO, "Japanese Society of Pharmaceutical Oncology"

20 JSPHCS, "Japanese Society of Pharmaceutical Health Care and Sciences"

21 JSHP, "Japanese Society of Hospital Pharmacists"

22 Ruder AD, "Is there a benefit to having a clinical oncology pharmacist on staff at a community oncology clinic?" 17 (17): 425-432, 2011

23 McKee M, "Impact of clinical pharmacy services on patients in an outpatient chemotherapy academic clinic" 17 (17): 387-394, 2011

24 American Society of Health-System Pharmacists, "Growing Trend Toward Specialization, Board Certification" American Society of Health-System Pharmacists

25 Ishikawa K, "Graduate Programs in Advanced Pharmacy Practice in Oncology in Japan" 74 (74): 111-, 2010

26 Chung C, "Development and implementation of an interdisciplinary oncology program in a community hospital" 68 (68): 1740-1747, 2011

27 Ignoffo R, "Board-Certified Oncology Pharmacists:Their Potential Contribution to Reducing a Shortfall in Oncology Patient Visits" 12 (12): e359-e368, 2016

28 "Board of Pharmacy Specialties" Board of Pharmacy Specialties

29 "Board of Pharmacy Specialties" Board of Pharmacy Specialties

30 Board of Pharmacy Specialties, "BPS Fall 2018 Candidate’s Guide updated" Board of Pharmacy Specialties

31 Hematology/Oncology Pharmacy Association, "BCOP Recertification Program Courses"

32 American College of Clinical Pharmacy, "ACCP Preparatory Review Resources"

33 Imamura M, "A Retrospective Study of the Effects of Oncology Pharmacist Participation in Treatment on Therapeutic Outcomes and Medical Costs" 40 (40): 1956-1962, 2017

34 보건복지부, "2016년 국가암등록통계 참고자료" 보건복지부